In the tumor microenvironment, cellular senescence is immunogenic, enhances MHC-1 antigen delivery, and can activate anti-tumor immune responses mediated by dendritic cells and CD8+ T cells (Marin et al., 2023). This evidence concerns the gene CD8A and neoplasm.